2018 ASCO/CAP Her2 Testing Guidelines in Breast Cancer. Impact of the Updated Guidelines on Breast Carcinomas Originally Classified as Her2 Equivocal - A Retrospective Analysis

被引：0
作者：
Alzeer, Ali [1 ]
Zeck, Jay [1 ]
Laureano, Julio [1 ]
Sidawy, Mary [1 ]
机构：
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
108
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Outcome of Repeat HER2 Testing After Initial Equivocal HER2 FISH Results Using 2013 ASCO/CAP Guidelines and Implications for Impact of Updated 2018 ASCO/CAP in Similar Cases
    Malone, V.
    Walker, J.
    Castriciano, G.
    Maguire, A.
    JOURNAL OF PATHOLOGY, 2020, 250 : 7 - 7
  • [22] ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia
    Farshid, Gelareh
    Bilous, Michael
    Morey, Adrienne
    Fox, Stephen
    Lakhani, Sunil
    Loi, Sherene
    Bell, Richard
    Spillane, Andrew
    PATHOLOGY, 2019, 51 (04) : 345 - 348
  • [23] Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study
    Wynton B. Overcast
    Jianying Zhang
    Debra L. Zynger
    Gary H. Tozbikian
    Virchows Archiv, 2016, 469 : 203 - 212
  • [24] Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study
    Overcast, Wynton B.
    Zhang, Jianying
    Zynger, Debra L.
    Tozbikian, Gary H.
    VIRCHOWS ARCHIV, 2016, 469 (02) : 203 - 212
  • [25] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Fang-Ping Xu
    Kun Wang
    Jie Xu
    Jie Chen
    Yi-Fang Zhang
    Hong-Mei Wu
    Ming-Hui Zhang
    Xiao-Xu Long
    Xin-Lan Luo
    Ke-Ping Zhang
    Dan-Yi Lin
    Yan-Hui Liu
    Breast Cancer Research and Treatment, 2017, 166 : 757 - 764
  • [26] Changing pattern for HER2 positivity due to updated ASCO/CAP guidelines for HER2 testing and its impact.
    Shah, Mithun Vinod
    Wiktor, Anne E.
    Meyer, Reid G.
    Tenner, Kathleen S.
    Ballman, Karla V.
    Ketterling, Rhett P.
    Perez, Edith A.
    Jenkins, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Xu, Fang-Ping
    Wang, Kun
    Xu, Jie
    Chen, Jie
    Zhang, Yi-Fang
    Wu, Hong-Mei
    Zhang, Ming-Hui
    Long, Xiao-Xu
    Luo, Xin-Lan
    Zhang, Ke-Ping
    Lin, Dan-Yi
    Liu, Yan-Hui
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (03) : 757 - 764
  • [28] Adding precision to 2018 ASCO/CAP HER2 testing guidelines in breast cancer with genomic profiling.
    Brufsky, Adam
    Crozier, Jennifer A.
    Chuba, Paul J.
    Lee, Sung Ho
    Menicucci, Andrea
    Kling, Heather M.
    Yoder, Erin
    Audeh, William
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] The Impact of 2013 ASCO/CAP Guidelines on the Breast Cancer Her2/Neu FISH Results
    Zhang, Songlin
    Wang, Xiaohong
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S144 - S144
  • [30] Impact of Recent 2018 ASCO-CAP HER2 Testing Guidelines on 2713 Breast Cancer Cases Treated According to 2013 ASCO-CAP HER2 Guidelines: Western Indian Tertiary Cancer Centre Experience
    Pai, T.
    Ankolkar, M.
    Shetty, O.
    Gurav, M.
    Dhanavade, S.
    Kadam, V.
    Tambe, S.
    Patil, A.
    Desai, S.
    Shet, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06) : 1227 - 1227
12345